MCA Stability Tool

Find stability recommendations for tablets and capsules.

Product Search

Incompatible

Adoport 5mg capsules (Sandoz Ltd)

Explore other Tacrolimus formulations Explore other Tacrolimus 5mg capsules suppliers

Stability Notes

Unsuitable for MCA. Keep in the original package to protect from light and moisture.

No Stability Information

Adoxal 25mg capsules (Essential-Healthcare Ltd)

Explore other Pyridoxal phosphate formulations Explore other Pyridoxal phosphate 25mg capsules suppliers

Stability Notes

There are no stability notes available for this medicine.

No Stability Information

Adoxal 25mg tablets (Essential-Healthcare Ltd)

Explore other Pyridoxal phosphate formulations Explore other Pyridoxal phosphate 25mg tablets suppliers

Stability Notes

There are no stability notes available for this medicine.

No Stability Information

Adoxal 50mg capsules (Essential-Healthcare Ltd)

Explore other Pyridoxal phosphate formulations Explore other Pyridoxal phosphate 50mg capsules suppliers

Stability Notes

There are no stability notes available for this medicine.

No Stability Information

Adoxal 50mg tablets (Essential-Healthcare Ltd)

Explore other Pyridoxal phosphate formulations Explore other Pyridoxal phosphate 50mg tablets suppliers

Stability Notes

There are no stability notes available for this medicine.

Incompatible

Advagraf 0.5mg modified-release capsules (Astellas Pharma Ltd)

Explore other Tacrolimus formulations Explore other Tacrolimus 500microgram modified-release capsules suppliers

Stability Notes

Unsuitable for MCA. Keep in the original package to protect from light and moisture.

Incompatible

Advagraf 1mg modified-release capsules (Astellas Pharma Ltd)

Explore other Tacrolimus formulations Explore other Tacrolimus 1mg modified-release capsules suppliers

Stability Notes

Unsuitable for MCA. Keep in the original package to protect from light and moisture.

Incompatible

Advagraf 1mg modified-release capsules (Pilsco Ltd)

Explore other Tacrolimus formulations Explore other Tacrolimus 1mg modified-release capsules suppliers

Stability Notes

Unsuitable for MCA. Keep in the original package to protect from light and moisture.

Incompatible

Advagraf 1mg modified-release capsules (Sigma Pharmaceuticals Plc)

Explore other Tacrolimus formulations Explore other Tacrolimus 1mg modified-release capsules suppliers

Stability Notes

Unsuitable for MCA. Keep in the original package to protect from light and moisture.

Incompatible

Advagraf 3mg modified-release capsules (Astellas Pharma Ltd)

Explore other Tacrolimus formulations Explore other Tacrolimus 3mg modified-release capsules suppliers

Stability Notes

Unsuitable for MCA. Keep in the original package to protect from light and moisture.

Incompatible

Advagraf 5mg modified-release capsules (Astellas Pharma Ltd)

Explore other Tacrolimus formulations Explore other Tacrolimus 5mg modified-release capsules suppliers

Stability Notes

Unsuitable for MCA. Keep in the original package to protect from light and moisture.

Incompatible

Advagraf 5mg modified-release capsules (Sigma Pharmaceuticals Plc)

Explore other Tacrolimus formulations Explore other Tacrolimus 5mg modified-release capsules suppliers

Stability Notes

Unsuitable for MCA. Keep in the original package to protect from light and moisture.

Incompatible

Affenid XL 18mg tablets (Zentiva Pharma UK Ltd)

Explore other Methylphenidate formulations Explore other Methylphenidate 18mg modified-release tablets suppliers

Stability Notes

Not suitable for compliance aid: packaged with a desiccant.

Provenance

This compatibility recommendation is derived from Concerta XL 18mg tablets (Janssen-Cilag Ltd).

Incompatible

Affenid XL 27mg tablets (Zentiva Pharma UK Ltd)

Explore other Methylphenidate formulations Explore other Methylphenidate 27mg modified-release tablets suppliers

Stability Notes

Not suitable for compliance aid: packaged with a desiccant.

Provenance

Compatibility recommendation derived from Concerta XL 27mg tablets (Janssen-Cilag Ltd)

Incompatible

Affenid XL 36mg tablets (Zentiva Pharma UK Ltd)

Explore other Methylphenidate formulations Explore other Methylphenidate 36mg modified-release tablets suppliers

Stability Notes

Not suitable for compliance aid: packaged with a desiccant.

Provenance

Compatibility recommendation derived from Concerta XL 36mg tablets (Janssen-Cilag Ltd).

Print this list

Compatible

Medicines suitable for use in MCAs, although use is likely to be off-label.  Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or consider up to 8 weeks if the MCA is airtight (sealed).  Consider the risk to the individual from potency loss or dose variability, particularly with unsealed devices.  Monitor for any changes in therapeutic effect or increased adverse effects after MCA initiation.

Use with caution

There are concerns about stability and/or there is a lack of stability data available. These medicines can theoretically be used in MCAs, although use is likely to be off-label.  Mitigation measures may need to be considered.  Keep medicines in MCAs for the shortest time necessary.  Generally, up to 5 weeks maximum unless otherwise specified, or consider up to 8 weeks if the MCA is airtight (sealed). Consider the risk to the individual from potency loss or dose variability, particularly with unsealed devices. Monitor for any changes in therapeutic effect or increased adverse effects after MCA initiation.

Incompatible

Medicines under this category are not suitable for use in MCAs.

No Stability Information

These medicines have not been reviewed by SPS.